ESC 365 - Genetic basis and molecular mechanisms in dilated cardiomyopathy (DCM)

CBS PREMIUM ACCESS

Genetic basis and molecular mechanisms in dilated cardiomyopathy (DCM)

Session: Hypertrophic and dilated cardiomyopathy: from molecular targets to therapy

Topic: Cardiomyopathies

Speaker: Professor J. van der Velden (Amsterdam, NL)

Event: Frontiers in CardioVascular Biomedicine 2024

Congress Presentation

Add to my library

About the speaker

Professor Jolanda van der Velden

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

13 presentations

2 followers

3 more presentations in this session

Cellular targets for drug therapy in HCM

Speaker: Doctor R. Coppini (Florence, IT)

Gene therapy in laminopathies and DCM

Speaker: Doctor A. Tijsen (Amsterdam, NL)

Meteorin-like regulates cardiac hypertrophy and associated metabolic plasticity during gestation and lactation

Speaker: Mr A. Blasco-Roset (Barcelona, ES)

Access the full session

Hypertrophic and dilated cardiomyopathy: from molecular targets to therapy

Speakers: Professor J. van der Velden, Doctor R. Coppini, Doctor A. Tijsen, Mr A. Blasco-Roset

About the event

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources